Congress funds long-overdue research into a debilitating condition affecting millions of women
H.R. 8160 — Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 · Filed by Yassamin Ansari (D-AZ) · 29 cosponsors · Introduced Mar 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the federal government to expand research into Premenstrual Dysphoric Disorder (PMDD), a severe menstrual condition affecting 5–8% of women and people assigned female at birth, by funding NIH research, public awareness campaigns, provider education, and training grants for health professionals. The bill authorizes unspecified federal spending across fiscal years 2026–2031 to improve diagnosis, treatment access, and reduce stigma around the condition.
Why we flagged it
The bill's operative mechanism is straightforward: it authorizes federal spending on NIH research, HHS awareness campaigns, and training grants for health professionals to address a neglected medical condition. No deregulation, tax carve-out, or private subsidy is present.
What the text implies
- The bill authorizes 'such sums as is necessary' without specifying dollar amounts, leaving actual spending levels to future appropriations decisions and potentially allowing the bill to remain unfunded.
- Section 5(e) expands the scope beyond PMDD training to include perimenopause and menopausal symptoms, broadening the bill's reach beyond its stated title focus.
- The requirement for 'adequate representation of diverse racial, ethnic, and socioeconomic populations' in research (Section 3(a)(3)) may improve equity but depends on enforcement and monitoring mechanisms not detailed in the bill.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands research, clinical training, and public awareness for a debilitating condition that is under-diagnosed and stigmatized, improving access to diagnosis and treatment for affected individuals. No restrictions on citizen rights or remedies are imposed; the bill is purely additive to public health capacity.
Who stands to gain
- accredited medical schools and nursing schools (grant recipients)
- accredited hospitals and residency programs (grant recipients)
- research institutions (potential grant recipients)
Named in the bill
National Institutes of Health (NIH), Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), accredited schools of medicine, nursing, pharmacy, accredited hospitals and residency programs
Where it stands
29 cosponsors: 29 Democrats.
- Mar 30, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $96,000 in lobbying spend. A filing names 31 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Yassamin Ansari, the sponsor, reported $234,033 in PAC receipts in the 2026 cycle.
- American College of Obstetricians and Gynecologists — $96,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (5,860 characters) on Apr 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds long-overdue research into a debilitating condition affecting millions of women” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8160 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.